Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:57:03 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  1.31.60·1.792.51.60-0.02-1.226.241351.64  1.64  1.603.53  1.1215:59:59May 0115 min RT 2¢
TSX - T1.31.60·1.792.51.60-0.02-1.22.74141.64  1.64  1.603.53  1.1215:59:5915 min
Pure - P 1.622.5491.63  1.63  1.6215:27:2715 min
Chi-X - X 1.6220.0331    May 1415 min
CXD - D 1.620.074    May 1615 min
TriAct - M 1.620.917    Sep 11-2015 min

Recent Trades - Last 10 of 35
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59T1.60-0.0220084 ITG8479 CIBCK
15:52:09M1.630.01407 TD Sec7 TD SecE
15:31:15D1.630.0127 TD Sec7 TD SecE
15:31:15T1.62 10014 Virtu ITG80 National BankK
15:31:10T1.62 10014 Virtu ITG80 National BankK
15:31:05T1.62 10014 Virtu ITG80 National BankK
15:31:04T1.62 30084 ITG8480 National BankK
15:31:04T1.62 10079 CIBC80 National BankK
15:27:27P1.62 50080 National Bank80 National BankK
15:27:27T1.62 20084 ITG8480 National BankK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-01 17:47C:MDP1.75News ReleaseMedexus's Metoject patent no longer in effect in Canada
2024-03-26 12:03C:MDP1.70News ReleaseMedexus gets Ixinity supplemental biologics licence OK
2024-02-07 19:36C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-07 19:36C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-07 18:09C:MDP2.70News ReleaseMedexus loses $500,000 (U.S.) in fiscal Q3 2024
2024-01-30 10:37C:MDP2.49News ReleaseMedexus to release Q3 2024 results Feb. 7
2024-01-08 10:44C:MDP2.87News ReleaseMedexus nail lacquer accepted for Health Canada review
2023-11-08 18:40C:MDP2.05News ReleaseMedexus loses $1.09-million (U.S.) in Q2 fiscal 2024
2023-11-08 07:56C:MDP2.05SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-08 07:44C:MDP2.05SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-01 12:27C:MDP2.03News ReleaseMedexus to release Q2 2024 results Nov. 8
2023-10-17 13:47C:MDP2.45News ReleaseMedexus completes $1.5M overallotment option
2023-10-16 13:11C:MDP2.49News ReleaseMedexus Pharmaceuticals repays convertible debentures
2023-10-06 21:01C:MDP2.79MiscellaneousMedexus 6% debentures to be delisted Oct. 16
2023-10-06 11:06C:MDP2.74News ReleaseMedexus Pharmaceuticals closes $10M public offering
2023-10-04 19:30C:MDP3.00Prospectus ApprovedMedexus Pharmaceuticals prospectus offering
2023-09-28 19:45C:MDP2.96News ReleaseMedexus amends outside date under medac licensing deal
2023-09-21 17:12C:MDP3.00News ReleaseMedexus shareholders elect seven directors at AGM
2023-09-05 19:05C:MDP3.13News ReleaseMedexus Pharmaceuticals arranges $10M public offering
2023-09-05 14:56C:MDPSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus